A Single-Center Experience
Radiation Oncologists, P.A. has cultivated a culture of innovation and an openness to adopting new tools that provide added p [...]
ArteraAI Prostate Test – 1 Pager 2024
This 1-page brochure provides a brief overview of the ArteraAI Prostate Test, including key features and benefits for clincia [...]
ArteraAI Prostate Test – Patient Brochure 2024
This patient brochure provides a brief overview of the ArteraAI Prostate Test, including its intended use, how it works, and [...]
ArteraAI Prostate Test Guide 2025
This test guide provides a comprehensive overview of the ArteraAI Prostate Test, including its intended use, how it works, an [...]
Artificial Intelligence in Prostate Cancer: Predicting Who ADT Can Help
This is a summary of results from a published scientific article. You can read the original article published in NEJM Evidenc [...]
Mind the Gap
While all men are at risk for prostate cancer, there are disproportionate gaps in treatment, research, clinical trials and mo [...]
Clinical Validation of a Multimodal Artificial Intelligence Prognostic Model in Localized and Advanced Disease
Artera has developed multimodal AI (MMAI)-enabled predictive and prognostic biomarkers for patients with prostate cancer usin [...]
ArteraAI Predictive Models
ArteraAI is a leading precision medicine company developing AI tests to personalize cancer therapy. Download the pdf.
ArteraAI Achieves SOC 2 Type II Security Compliance Certification
ArteraAI x SOC 2 As part of our commitment to cybersecurity, we are proud to announce that ArteraAI is now SOC 2 Type II cert [...]